Avigan, the experimental drug to treat ebola has been authorised by Guinea's government to be used in Ebola treatment centres.

Guinea's anti-Ebola task force said about two dozen new cases of Ebola had been recorded in the last two weeks, taking the total number to 53 as of Friday. Officials are accessing villages where they had previously faced local resistance to their presence.
French and Guinean teams in southern Guinea have tested the experimental Japanese drug Avigan, or favipiravir developed by Toyama Chemical, a subsidiary of Japan’s Fujifilm, since mid-December.
French President Francois Hollande's office said that the results had been positive and the drug appeared to accelerate the recovery process of patients.
"We have decided to broaden the use of this drug. It will only be available in the Ebola Treatment Units, not the hospitals," said Sakoba Keita, coordinator of Guinea's Ebola response.
Health officials have not provided any data for the results of the trials of the anti-Ebola drug. Favipiravir has been distributed to the town of Coyah after testing in Gueckedou and Nzerekore and talks are underway to start the treatment in the capital, Conakry.
Advertisement
Source-Medindia